This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Center Laboratories, Inc., Medical and Pharmaceutical Industry Technology and Development Center. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 6 
1 out of 16 Years Active: 2021-2023
Title: Tse-Ching Lin: Innovator in Pharmaceutical Composition
Introduction
Tse-Ching Lin is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of two patents to his name, Lin's work focuses on improving treatment methods for mental disorders and neurodegenerative conditions.
Latest Patents
Lin's latest patents include a modified release pharmaceutical composition and a method for the treatment of mental disorders. This invention involves a modified release pharmaceutical composition that comprises an effective amount of at least one antipsychotic agent. The design ensures that the antipsychotic agent(s) are released in a manner that aligns with the physiological and chronotherapeutic needs of patients. Another significant patent is an oral pH-independent dosage formulation for treating neurodegenerative disorders. This formulation contains both sustained-release and immediate-release drugs, specifically memantine and donepezil. It is characterized by a pH-independent dissolution profile of memantine across a pH range from about 1.0 to about 7.0.
Career Highlights
Throughout his career, Tse-Ching Lin has worked with prominent organizations in the medical and pharmaceutical sectors. Notable companies include the Medical and Pharmaceutical Industry Technology and Development Center and Center Laboratories, Inc. His work in these institutions has contributed to advancements in pharmaceutical technology and drug development.
Collaborations
Lin has collaborated with several professionals in his field, including Chih-Chiang Yang and Lai-Cheng Chin. These collaborations have fostered innovation and the sharing of knowledge in pharmaceutical research.
Conclusion
Tse-Ching Lin's contributions to pharmaceutical innovations demonstrate his commitment to improving treatment options for patients with mental and neurodegenerative disorders. His patents reflect a deep understanding of drug formulation and patient needs, marking him as a significant figure in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile